Axon CEO trades 70 shares in Rule 10b5-1 sale

Axon Enterprise, Inc. director and chief executive officer Patrick W. Smith reported a sale of 70 shares of common stock on August 7, 2026 at a weighted average price of $566.6186 per share, executed under a Rule 10b5-1 trading plan adopted on May 12, 2025.

Rhea-AI Filing Summary

Axon Enterprise, Inc. director and chief executive officer Patrick W. Smith reported a sale of 70 shares of common stock on August 7, 2026 at a weighted average price of $566.6186 per share, executed under a Rule 10b5-1 trading plan adopted on May 12, 2025. Following this transaction, he held 3,030,997 shares of Axon common stock directly.

Insider Trade Summary 10b5-1

Net Seller: 70 shares

Net Sell 1 txn

Insider SMITH PATRICK W

Role CHIEF EXECUTIVE OFFICER

Sold 70 shs ($40K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	70	$566.6186	$40K

Holdings After Transaction: Common Stock — 3,030,997 shares (Direct)

Footnotes (2)

1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
2. F2. The transaction was executed in multiple trades at prices ranging from $566.55 to $566.84. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 70 shares Weighted average sale price: $566.6186 per share Shareholding after transaction: 3,030,997 shares +2 more

5 metrics

Shares sold 70 shares Common stock sale on August 7, 2026

Weighted average sale price $566.6186 per share Weighted average of multiple trades ranging $566.55–$566.84

Shareholding after transaction 3,030,997 shares Direct ownership following reported sale

Trade price range $566.55 to $566.84 Range of prices at which the 70 shares were sold

10b5-1 plan adoption date May 12, 2025 Date reporting person adopted the Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, weighted average sales price, Form 4, line-item limitation

4 terms

Rule 10b5-1 trading plan regulatory

"The transactions were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sales price financial

"The price reported above reflects the weighted average sales price"

Form 4 regulatory

"this is the second of two Forms 4 being filed"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

line-item limitation regulatory

"Due to a 30 line-item limitation in Table 1"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AXON CEO Patrick W. Smith report in this Form 4 transaction?

Patrick W. Smith reported a sale of 70 shares of Axon Enterprise common stock. The transaction occurred on August 7, 2026 and was reported as a routine insider trade under SEC rules.

At what price were the AXON shares sold in this Form 4 filing?

The 70 Axon shares were sold at a weighted average price of $566.6186 per share. The trade was executed in multiple transactions between $566.55 and $566.84 per share.

How many AXON shares does Patrick W. Smith own after this reported sale?

After the reported sale, Patrick W. Smith directly owned 3,030,997 shares of Axon Enterprise common stock. This figure reflects his post-transaction holdings as disclosed in the Form 4.

Was the AXON insider transaction made under a Rule 10b5-1 trading plan?

Yes. The filing states the sale was effected under a Rule 10b5-1 trading plan adopted by Patrick W. Smith on May 12, 2025, indicating a pre-arranged, systematic trading program.

Is this AXON Form 4 part of multiple insider transaction reports?

Yes. The remarks explain this is the second of two Forms 4 filed by the reporting person, due to a 30 line-item limitation in the non-derivative transaction table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/11/2026 - 04:41 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SMITH PATRICK W

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE ARIZONA 85255

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2026		S(1)		70	D	$566.6186(2)	3,030,997	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

2. The transaction was executed in multiple trades at prices ranging from $566.55 to $566.84. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

Due to a 30 line-item limitation in Table 1, this is the second of two Forms 4 being filed by the Reporting Person.

	/s/ Patrick W. Smith by Isaiah Fields, Attorney-in-Fact	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)